Seagen
E854988
Seagen is a biotechnology company specializing in the development of antibody-drug conjugate (ADC) therapies for cancer treatment.
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
public company ⓘ |
| acquiredBy | Pfizer NERFINISHED ⓘ |
| acquisitionAnnounced | 2022 ⓘ |
| acquisitionValueUSD | 43000000000 ⓘ |
| AdcetrisIndication |
Hodgkin lymphoma
NERFINISHED
ⓘ
systemic anaplastic large cell lymphoma ⓘ |
| collaboratesWith |
Astellas Pharma
NERFINISHED
ⓘ
Genmab NERFINISHED ⓘ Merck & Co. NERFINISHED ⓘ Takeda Pharmaceutical Company NERFINISHED ⓘ |
| coreModality |
cytotoxic payloads
ⓘ
linker technologies NERFINISHED ⓘ monoclonal antibodies ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| developed |
Adcetris
NERFINISHED
ⓘ
enfortumab vedotin NERFINISHED ⓘ |
| focusesOn |
cancer treatment
ⓘ
targeted cancer therapies ⓘ |
| formerName | Seattle Genetics NERFINISHED ⓘ |
| foundedBy |
Clay Siegall
NERFINISHED
ⓘ
H. Perry Fell NERFINISHED ⓘ |
| hasEmployeeType |
clinical researchers
ⓘ
scientists ⓘ |
| hasProduct |
Adcetris
NERFINISHED
ⓘ
Padcev NERFINISHED ⓘ Tukysa NERFINISHED ⓘ |
| hasTechnology | antibody-drug conjugate platform ⓘ |
| hasTherapy |
brentuximab vedotin
NERFINISHED
ⓘ
enfortumab vedotin NERFINISHED ⓘ tisotumab vedotin NERFINISHED ⓘ tucatinib NERFINISHED ⓘ |
| headquartersLocation | Bothell, Washington NERFINISHED ⓘ |
| inception | 1997 ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| locatedIn |
Washington
ⓘ
surface form:
Washington (state)
|
| PadcevIndication | urothelial carcinoma ⓘ |
| regulatoryRegion | FDA-approved products ⓘ |
| researchArea |
hematologic malignancies
ⓘ
solid tumors ⓘ |
| specializesIn |
antibody-drug conjugates
ⓘ
oncology therapeutics ⓘ |
| tickerSymbol | SGEN NERFINISHED ⓘ |
| tisotumabVedotinIndication | recurrent or metastatic cervical cancer ⓘ |
| tradedOn | NASDAQ NERFINISHED ⓘ |
| TukysaIndication | HER2-positive breast cancer ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.